Change of Number of Shares and Votes in Karolinska Development
(Thomson Reuters ONE) -
STOCKHOLM - August 31, 2017. The number of series B shares in Karolinska
Development AB (Nasdaq Stockholm: KDEV) has increased by 24,404 shares via
conversion of convertible loans and allotment of shares to participants in the
share-based incentive program (PSP 2014) decided by the Annual General Meeting
in 2014.
Today, the last trading day of the month, there are 64,361,100 shares,
representing a total of 77,888,982 votes outstanding in the Company, distributed
among 1,503,098 shares of series A (with 15,030,980 votes) and 62 858 002 shares
of series B (with 62 858 002 votes).
For further information, please contact:
Viktor Drvota, CEO, Karolinska Development AB
Phone: +46 73 982 52 02, e-mail: viktor.drvota(at)karolinskadevelopment.com
Ulf Richenberg, General Counsel, Karolinska Development AB
Phone: +46 70 29 860 25, e-mail: ulf.richenberg(at)karolinskadevelopment.com
TO THE EDITORS
About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences
investment company. The company focuses on identifying breakthrough medical
innovations in the Nordic region that are developed by entrepreneurs and
leadership teams. The Company invests in the creation and growth of companies
that advance these assets into commercial products that are designed to make a
difference to patients' lives while providing an attractive return on investment
to shareholders.
Karolinska Development has access to world-class medical innovations at the
Karolinska Institutet and other leading universities and research institutes in
the Nordic region. The Company aims to build companies around scientists who are
leaders in their fields, supported by experienced management teams and advisers,
and co-funded by specialist international investors, to provide the greatest
chance of success.
Karolinska Development has established a portfolio of nine companies targeting
opportunities in innovative treatment for life-threatening or serious
debilitating diseases.
The Company is led by an entrepreneurial team of investment professionals with a
proven track record as company builders and with access to a strong global
network.
For more information, please visit www.karolinskadevelopment.com
This information is information that Karolinska Development AB (publ) (Nasdaq
Stockholm: KDEV) is obliged to make public pursuant to the Financial Instruments
Trading Act. The information was submitted for publication, through the agency
of Viktor Drvota, at 08.00 CET on August 31, 2017.
KDev shares and votes Aug 17:
http://hugin.info/143071/R/2127460/812419.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 31.08.2017 - 08:00 Uhr
Sprache: Deutsch
News-ID 558374
Anzahl Zeichen: 3358
contact information:
Town:
Solna
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Change of Number of Shares and Votes in Karolinska Development"
steht unter der journalistisch-redaktionellen Verantwortung von
Karolinska Development AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
